Net profit of Gennex Laboratories rose 74.92% to Rs 5.37 crore in the quarter ended September 2024 as against Rs 3.07 crore during the previous quarter ended September 2023. Sales rose 79.47% to Rs 31.55 crore in the quarter ended September 2024 as against Rs 17.58 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales31.5517.58 79 OPM %23.6132.82 - PBDT7.244.99 45 PBT6.123.95 55 NP5.373.07 75 Powered by Capital Market - Live News

Net profit of Gennex Laboratories rose 56.39% to Rs 4.16 crore in the quarter ended September 2024 as against Rs 2.66 crore during the previous quarter ended September 2023. Sales rose 73.38% to Rs 24.69 crore in the quarter ended September 2024 as against Rs 14.24 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales24.6914.24 73 OPM %15.0327.88 - PBDT5.483.75 46 PBT5.013.55 41 NP4.162.66 56 Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live News

Gennex Laboratories announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live News

Gennex Laboratories will hold a meeting of the Board of Directors of the Company on 6 September 2024.Powered by Capital Market - Live News